FDA Device Intelligence
HomeBRIGHTWAKE LIMITED › Advazorb Heel

Advazorb Heel

BRIGHTWAKE LIMITED · Model CR4502 · UDI-DI 05060031476460

NAC
4
510(k) clearances
1,404
Adverse events (6 deaths)
9
Recalls
501
Facilities

Description

Absorbent foam dressing with film backing, 17cm X 21cm. Advazorb Heel is a conformable, non-adherent, absorbent, polyurethane foam dressing with a breathable film backing designed to fit around the heel. A non-adherent foam dressing with excellent fluid handling properties. Ideal for use under compression bandaging with its fluid retention, low profile and low friction film backing. Advazorb Heel also contributes to a pressure relieving protocol when used in conjunction with pressure relieving devices.

Recalls

DateFirmReason
2026-05-18DeRoyal Industries IncSterile wound dressing, lacks sterility assurance
2025-02-19MEDLINE INDUSTRIES, LP - NorthfieldThere is a potential for the sterility of the device to be compromised.
2024-10-01Advanced Medical Solutions Ltd.Due to defects on primary packaging pouch that compromise the device's ability to maintain a sterile barrier.
2024-10-01Advanced Medical Solutions Ltd.Due to defects on primary packaging pouch that compromise the device's ability to maintain a sterile barrier.
2024-10-01Advanced Medical Solutions Ltd.Due to defects on primary packaging pouch that compromise the device's ability to maintain a sterile barrier.
2024-02-27ConvaTec, IncThe product does not meet sterility assurance level.
2024-01-23MEDLINE INDUSTRIES, LP - NorthfieldProduct failed sterility testing.
2016-06-08Amd-Ritmed, Inc.The lot of transparent dressing was found to be contaminated (not sterile) based on FDA sampling and analysis.
2004-01-19DeRoyal Surgical TrayHydrophilic powder wound dressing, sterilized at a dosage which subsequently failed a sterility audit, was distributed.

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.